Clinical Review

Both vedolizumab and ustekinumab are safe to use in pregnant women with inflammatory bowel disease (IBD), as reported in a study.

Pelvic organ prolapse (POP) after delivery appears to result in poorer sexual function, quality of life (QoL), and psychological health, suggests a China study.

Having greater serum folic acid levels and taking folic acid supplements more than once a week during the second and third trimesters appear to lower the risk of Kawasaki disease among infants, according to a study.

Treatment with metformin plus insulin early in pregnancy for women with pre-existing type 2 diabetes (T2D) or gestational diabetes falls short of reducing the risk of adverse neonatal outcomes, as shown in the MOMPOD study.

One in five young BRCA carriers with breast cancer subsequently conceive within 10 years, without any detrimental effect on disease-free survival, according to a study.

A diet rich in cholesterol during early pregnancy and genetic variations of cholesterol metabolism genes both contribute to the risk of gestational diabetes mellitus (GDM), suggests a study.

The presence of anorexia nervosa during pregnancy may contribute to elevated risks of clinically important adverse pregnancy outcomes, with a significant proportion of the excess risk due to an underweight prepregnancy body mass index (BMI) or gestational weight gain below the recommendation, as shown in a study.

Women who consume energy drinks before pregnancy may potentially be at increased risk of gestational hypertension, as reported in a study.

Treatment with fezolinetant 45 mg outperforms other nonhormone therapies (non-HTs) in terms of minimizing the frequency of moderate-to-severe vasomotor symptoms (VMS) in women undergoing menopause, according to a study from the US.

Women with a history of gestational diabetes mellitus (GDM) are at higher risk of developing nonalcoholic fatty liver disease (NAFLD), suggests a recent study.